Colon Cancer News and Research

Latest Colon Cancer News and Research

Epigenomic test that could improve treatment for specific gastric cancers

A study by researchers at the John Wayne Cancer Institute at Saint John's Health Center in a recent issue of Journal of Clinical Oncology identifies activation of the enzyme COX-2 in gastric cancer tumors as a prognostic indicator for poor outcome.

12 Dec 2007

Keeping at-risk cells from developing cancer

Researchers at Johns Hopkins have discovered that cancers arising from epigenetic changes - in this case the inappropriate activation of a normally silent gene - develop by becoming addicted to certain growth factors.

10 Dec 2007

Being fit more important than being fat when it comes to a longer life

The latest research is saying that fitness may be more important when it comes to living longer, than being overweight.

5 Dec 2007

Prolonged exposure to night shift work increases odds of cancer

A study by the World Health Organization has found that night shift work increases the risk of cancer in humans.

3 Dec 2007

DNA methylation shown to promote development of colon tumors

Damaged or defective genes have long been known to be the cause of some cancers.

2 Dec 2007

Transporters may help delay diabetes-related retinal damage

Two transporters that deliver alternative energy sources to the eye may help delay retinal damage that can occur in diabetes, researchers say.

29 Nov 2007

Scientists observe gene activity outside the body

Researchers at Jefferson Medical College and Jefferson's Kimmel Cancer Center in Philadelphia have used PET imaging to see hyperactive cancer genes inside breast tumors in laboratory animals, marking the first time such gene activity has been observed from outside the body.

29 Nov 2007

Narrow band imaging colonoscopy identifies flat dysplastic lesions in ulcerative colitis patients

A pilot study from researchers at Kyushu University in Fukuoka, Japan, found that narrow band imaging (NBI) colonoscopy used in cancer surveillance for ulcerative colitis patients can identify flat dysplastic lesions.

19 Nov 2007

CT colonography used in elderly patients detects a high number of abnormalities outside the colon

CT colonography (CTC), when used in elderly patients, can detect a high number of new and significant abnormalities outside the colon (including cirrhosis and tumors) and is well tolerated, according to a recent study conducted by researchers at St. James's University Hospital in Leeds, United Kingdom (UK).

16 Nov 2007

Freeze-dried grape powder blocks genes linked to colon cancer

Low doses of freeze-dried grape powder inhibit genes linked to the development of sporadic colorectal cancer, University of California, Irvine cancer researchers found.

15 Nov 2007

Former Chair of Presidential Advisory Council on HIV/AIDS Hitt passes away

R. Scott Hitt -- a former HIV/AIDS physician and former chair of the Presidential Advisory Council on HIV/AIDS during the Clinton administration -- died Thursday of colon cancer at his home in West Hollywood, Calif., according to Hitt's friend and West Hollywood Mayor John Duran, the AP/San Francisco Chronicle reports.

12 Nov 2007

Food fortification with folic acid linked to increased cancer rate

Two recent commentaries appearing in the November issue of Nutrition Reviews find that the introduction of flour fortified with folic acid into common foods was followed by an increase in colon cancer diagnoses in the U.S. and Canada.

5 Nov 2007

Increased glucose level is a strong risk factor for colorectal cancer

Diabetes is a very common illness that affects more than 20 million people in the U.S. and it is estimated an additional 54 million Americans have pre-diabetes, a condition that occurs when a person's blood glucose levels are higher than normal but not high enough for a diagnosis of type 2 diabetes.

2 Nov 2007

Supplements do not reduce cancer risk

Most experts agree that supplements add little, if anything, to a well-balanced diet.

2 Nov 2007

Bevacizumab improves ovarian cancer treatment

A new study appearing in International Journal of Gynecological Cancer states that Bevacizumab, a biologic anti-cancer agent that prevents tumor growth by interfering with the formation of new blood vessels, may have the potential to improve the efficacy of standard combination chemotherapy in ovarian cancer.

1 Nov 2007